Why I Stopped Asking About Budget (and You Should Too)

My first sales manager drilled one question into me: 'Do you have budget allocated?' I repeated it on every call, like a robot. Half the time, the answer was a polite 'no'—and we moved on. But there was one call that changed everything.

The prospect said 'no budget.' But I kept asking about their problems. Turns out, they were bleeding money on a broken process, and they had an emergency fund earmarked for fixes. We closed a six-figure deal. BANT would have killed it.

BANT is an IBM relic from the 1950s. It was built for a time when sales were simple, products were cheap, and buyers weren't drowning in options. Today, it's a crutch. It gives you false confidence—you check four boxes and assume the deal is real, but you've missed the actual driver: pain.

So I've spent the last few years using and teaching three frameworks: BANT, MEDDIC, and SPIN. Here's the unvarnished truth: BANT is for amateurs, MEDDIC is for enterprise heavyweights, and SPIN is a discovery superpower. Let me show you why.

BANT: The Checklist That Lied to You

BANT is a checklist, not a strategy. It filters, but it filters out the deals that could save your quarter. The problem? You're asking the wrong questions. You're asking about budget, authority, need, and timing, but you're not digging into the buyer's pain. And pain is what drives decisions—not budget.

I remember a deal where the buyer said 'no budget.' But when I asked about their struggles, they lit up. Turns out, they had a project that was failing, and they were desperate. The budget came from a different pot—like an emergency fund. BANT would have killed that deal.

In complex sales, BANT fails because it assumes a linear process. But enterprise deals are messy: budget is fuzzy, authority is scattered across a committee, and timing is a moving target. BANT doesn't capture that.

Here's a stat that should scare you: 61% of B2B marketers send all leads to sales, but only 27% are actually qualified. BANT is part of the problem—it gives you false confidence.

MEDDIC: Built for the Enterprise Grind

MEDDIC (Metrics, Economic Buyer, Decision Criteria, Decision Process, Implicate the Pain, Champion, Competition) is BANT's opposite. It forces you to dig deep—into the metrics, the economic buyer, the champion, and the pain. It was built for complex, enterprise sales where the stakes are high and the process is long.

What I love about MEDDIC is its specificity. You have to identify the economic buyer, the decision process, and a champion. You have to quantify the problem—put a number on the pain. And you have to implicate the pain—make the buyer feel the consequences of doing nothing. That's where the magic happens.

And the numbers back it up: MEDDICC claims teams using MEDDPICC see a 62% increase in deal size, win rates jump from 23% to 46%, and forecast accuracy improves from 25% to 85%. That's not a typo. That's what happens when you qualify on pain.

But MEDDIC is heavy. It's overkill for a $5,000 deal. It's designed for deals where you need to navigate a complex buying committee, and missing a step can cost you the deal.

SPIN: The Art of Asking Questions

SPIN Selling (Situation, Problem, Implication, Need-Payoff) is all about questions. Developed by Neil Rackham after analyzing over 35,000 sales calls, SPIN is based on the largest research project ever undertaken in selling. It's designed for high-value products and services, where conventional selling methods are 'doomed to fail'.

The four question types—situation, problem, implication, need-payoff—are designed to deepen discovery and uncover the pain that BANT misses. You start by understanding the situation, then you surface the problem, then you make the buyer feel the implications of not solving it, and finally you help them see the payoff of solving it.

I've used SPIN in discovery calls, and it's like a cheat code. One time, I asked an implication question—'What happens if you don't fix this by Q4?'—and the buyer went silent. Then he said, 'We'd lose our biggest client.' That's when I knew we had a deal.

But SPIN is a skill, not a checklist. It requires practice and discipline. And it doesn't give you the same structural rigor as MEDDIC for navigating the political landscape of an enterprise deal.

BANT vs. MEDDIC vs. SPIN: The Brutal Comparison

Let's be blunt: BANT is for amateurs. If you're selling anything over $100K, you're leaving money on the table by using BANT. MEDDIC is the enterprise heavyweight—rigorous, structured, and forces you to qualify on pain, not budget. SPIN is the questioning master—a skill that transforms your discovery calls and builds urgency.

Who Should Use Which?

If you're still using BANT because it's comfortable, here's your wake-up call. If your average deal is under $100K and your sales cycle is short, BANT might not be a total disaster. But if you're selling to enterprises, you need to ditch BANT and adopt MEDDIC. You need to know the economic buyer, the decision criteria, and the champion. You need to implicate the pain with hard metrics.

Not ready for MEDDIC's full structure? Start with SPIN. Learn to ask better questions. Master the implication question—it's the one that creates urgency. The Challenger research found that more than 53% of what drives B2B customers' purchase decisions is the salesperson's ability to teach the customer something new or challenge their thinking. SPIN's implication questions do exactly that—they challenge the buyer's thinking about the cost of doing nothing.

And here's a quick warning: Don't fall for the 'no budget' objection. It's often about risk or timing, not money. Dig deeper. Ask about the implications of the problem. That's where the urgency is.

My Verdict: MEDDIC Wins the Enterprise, SPIN Wins the Discovery

Here's my bottom line: For any deal over $100K, use MEDDIC. It's the only framework that forces you to qualify on pain, not budget, and it gives you the structure to navigate complex deals. For everything else, SPIN is your best bet—it's a skill that will make you a better prospector regardless of deal size.

BANT is a relic. It's a filter that keeps your pipeline full of unqualified leads. And if you're still relying on it, you're going to keep missing your quota. The Salesforce State of Sales report found that 67% of sales reps didn't expect to meet quota that year. Don't be one of them.

So, stop asking about budget and start asking about pain. Use MEDDIC to qualify the deal, and use SPIN to uncover the pain. That's the combination that wins.

Bottom Line

Your single best move: Adopt MEDDIC for enterprise deals and SPIN for discovery. Ditch BANT for anything over $100K. Qualify on pain, not budget, and watch your win rates climb.

Sources

• Sales qualification frameworks (Wikipedia) - https://en.wikipedia.org/wiki/Sales
• SPIN Selling (book record, academic library catalogs) - https://ebooks.mpdl.mpg.de/ebooks/Record/EB001945872/Description
• MEDDICC official site - https://meddicc.com/
• Sales funnel and metrics (Wikipedia) - https://en.wikipedia.org/wiki/Sales
• The Challenger Sale research (Forbes, by the authors) - https://www.forbes.com/sites/forbesleadershipforum/2012/02/03/the-one-kind-of-sales-rep-who-does-best-at-b2b/
• Salesforce State of Sales (news release) - https://www.salesforce.com/news/stories/sales-ai-statistics-2024/